Large-scale testing (Phase 3)Study completedNCT01063621What this trial is testingExtended Long-Term Safety Study of KW-6500Who this might be right forParkinson's Disease Kyowa Kirin Co., Ltd. 27
Post-approval studies (Phase 4)Study completedNCT04986995What this trial is testingOpicApone Sleep dISorderWho this might be right forParkinson Disease Bial - Portela C S.A. 22
Testing effectiveness (Phase 2)Study completedNCT00761137What this trial is testingSafety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease PatientsWho this might be right forSialorrhea Secondary to Parkinson's Disease NeuroHealing Pharmaceuticals Inc. 19
Not applicableNot Yet RecruitingNCT06755645What this trial is testingTransforming Parkinson's Care With Predictive AlgorithmsWho this might be right forParkinson University Ramon Llull 200
Testing effectiveness (Phase 2)Study completedNCT00888004What this trial is testingEfficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease PatientsWho this might be right forParkinson's DiseaseL-dopa Induced Dyskinesia Novartis 28
Not applicableStudy completedNCT04383665What this trial is testingLow Frequency Subthalamic Nucleus Deep Brain Stimulation to Improve Verbal FluencyWho this might be right forParkinson Disease University of Southern California 12
Testing effectiveness (Phase 2)WithdrawnNCT02857244What this trial is testingA Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsWho this might be right forParkinson's Disease University of Chicago
Testing effectiveness (Phase 2)Study completedNCT00460148What this trial is testingParkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of RopiniroleWho this might be right forParkinson Disease GlaxoSmithKline 28
Testing effectiveness (Phase 2)Study completedNCT03845387What this trial is testingA Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.Who this might be right forParkinson Disease Kissei Pharmaceutical Co., Ltd. 74
Post-approval studies (Phase 4)UnknownNCT01780467What this trial is testingRole of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian PatientsWho this might be right forParkinson's Disease University Hospital, Clermont-Ferrand 40
Not applicableStudy completedNCT07264114What this trial is testingAquatic High-Intensity Interval Training for Parkinson's DiseaseWho this might be right forParkinson Disease Pardis Specialized Wellness Institute 56
Large-scale testing (Phase 3)Study completedNCT00200512What this trial is testingContinued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsWho this might be right forParkinson Disease Mylan Bertek Pharmaceuticals 16
Not applicableEnded earlyNCT01701128What this trial is testingThe Effect of Exercise Training on Gait and Quality of Life in Parkinson's DiseaseWho this might be right forParkinson's Disease Laval University 35
Testing effectiveness (Phase 2)Study completedNCT00224263What this trial is testingEfficacy and Safety of Lingzhi in Patients With Early Parkinson's DiseaseWho this might be right forParkinson's Disease Xuanwu Hospital, Beijing 360
Testing effectiveness (Phase 2)Study completedNCT01172379What this trial is testingA Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period DyskinesiasWho this might be right forParkinson's Disease Eisai Limited 2
Not applicableStudy completedNCT03193489What this trial is testingTwo-year Follow-up to High-intensity Multi-component Agility Intervention That Improves Clinical and Motor Symptoms of Parkinson's DiseaseWho this might be right forFollow upParkinson DiseaseRehabilitation Somogy Megyei Kaposi Mór Teaching Hospital 3
Post-approval studies (Phase 4)Study completedNCT00485069What this trial is testingREQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 StudyWho this might be right forParkinson DiseaseParkinson's Disease GlaxoSmithKline 123
Testing effectiveness (Phase 2)Ended earlyNCT02906020What this trial is testingA Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene MutationWho this might be right forParkinson's Disease Genzyme, a Sanofi Company 273
Large-scale testing (Phase 3)Study completedNCT00957203What this trial is testingLong-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease PatientsWho this might be right forParkinson's Disease Kyowa Kirin Co., Ltd. 308
Not applicableEnrolling By InvitationNCT06586320What this trial is testingQuantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to TreatmentWho this might be right forParkinson Disease Stardots AB 40